source
- Biopharma layoffs must double in second half of 2026 to match 2025 cutsThe first half of 2026 saw biopharma companies cut slightly fewer jobs than the same period a year earlier, with layoffs affecting about 2% fewer employees overall. To reach the total workforce re…
- Roche stresses careful AI token use and pauses drug from Carmot acquisitionRoche's CEO Thomas Schinecker said the company is adopting a thoughtful approach to how it employs AI tokens, emphasizing responsible use. He noted that AI tools have already helped increase the n…